Overview
Thyroid infection, particularly in the context of thyroid-associated ophthalmopathy (TAO), involves inflammatory processes affecting the thyroid gland and ocular tissues, leading to symptoms such as proptosis, diplopia, and visual field defects. 13Diagnosis
Clinical assessment focusing on ocular symptoms (proptosis, diplopia, visual field defects).
Imaging studies (e.g., CT, MRI) to evaluate orbital inflammation and structural changes.
Laboratory tests including thyroid function tests (TSH, free T4, T3) and inflammatory markers (ESR, CRP).
Grading systems like the Clinical Activity Score (CAS) and NOSPECS criteria for severity assessment. 13Management
First-line treatment: Glucocorticoid pulse therapy for moderate to severe active TAO. 1
Adjunctive treatments:
- Mycophenolate mofetil combined with glucocorticoids.
- Teprotumumab for patients with contraindications to glucocorticoids.
- 99Tc-MDP for improving clinical activity scores and proptosis.
- Statins combined with glucocorticoids to improve quality of life and diplopia scores. 1
Surgical interventions: Orbital decompression surgery for severe cases with significant proptosis and visual impairment. 5
Anterior segment procedures: Topical anesthesia for inferior rectus recession to correct restrictive hypotropia in thyroid ophthalmopathy. 6Special Populations
Pregnancy: Limited evidence; management typically involves conservative approaches with close monitoring due to potential risks of systemic glucocorticoids. 1
Elderly: Consideration of comorbidities and potential drug interactions; tailored treatment plans focusing on minimizing side effects. 1Key Recommendations
For moderate to severe active thyroid-associated ophthalmopathy, initiate treatment with glucocorticoid pulse therapy. (Evidence: Strong 1)
In patients contraindicated to glucocorticoids, consider mycophenolate mofetil combined with glucocorticoids, Teprotumumab, or 99Tc-MDP as alternative treatments. (Evidence: Moderate 1)
For restrictive myopathy in thyroid ophthalmopathy, utilize topical anesthesia during inferior rectus recession to optimize surgical outcomes. (Evidence: Weak 6)
In cases of severe orbital involvement leading to visual impairment, perform orbital decompression surgery using a combined ophthalmic-otolaryngologic approach. (Evidence: Expert opinion 5)References
1 Jinhai Y, Qassem AAM, Qi J, Chao X, Anan W, Qi X et al.. Bayesian network analysis of drug treatment strategies for thyroid associated ophthalmopathy. International ophthalmology 2024. link
2 Kang YJ, Stybayeva G, Hwang SH. Surgical safety and effectiveness of bilateral axillo-breast approach robotic thyroidectomy: a systematic review and meta-analysis. Brazilian journal of otorhinolaryngology 2024. link
3 Ye J, Liu W, Hu X, Jiang H, Xu M, Jin H et al.. Elevated pulse pressure correlated with reduced retinal peripapillary capillary in thyroid-associated ophthalmology with visual field defect. Frontiers in endocrinology 2022. link
4 Russell CF. Management of thyroid tumours. British journal of hospital medicine 1997. link
5 Kulwin DR, Cotton RT, Kersten RC. Combined approach to orbital decompression. Otolaryngologic clinics of North America 1990. link
6 Harper DG. Topical anesthesia for inferior rectus recession in thyroid ophthalmopathy. Annals of ophthalmology 1978. link